NSPR

InspireMD, Inc. NASDAQ Listed Apr 12, 2011

Healthcare ·Medical - Devices ·IL · inspiremd.com

$1.16

Mkt Cap $54.4M

52w Low $1.02 7.3% of range 52w High $2.93

50d MA $1.50 200d MA $1.96

P/E (TTM) -1.5x

EV/EBITDA -2.6x

P/B 1.5x

Debt/Equity 0.0x

ROE -88.4%

P/FCF -3.6x

RSI (14) —

ATR (14) —

Beta 0.94

50d MA $1.50

200d MA $1.96

Avg Volume 40.1K

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

SIC Code

3841

CIK (SEC)

1433607

Phone

888 776 6804

4 Menorat Hamaor Street · Miami, FL 6744832 · IL

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 4, 2026	AMC	-0.19	-0.16	+15.8%	1.17	-12.8%	-6.0%	+5.5%	+0.0%	—	—	—
Mar 18, 2026	AMC	-0.22	-0.14	+36.4%	1.79	+0.0%	-4.5%	+5.8%	-3.9%	+2.9%	-1.1%	—
Nov 4, 2025	AMC	-0.17	-0.17	+0.0%	2.13	+0.0%	-0.9%	-7.1%	-7.7%	-7.2%	-3.0%	—
Aug 4, 2025	AMC	-0.24	-0.26	-8.3%	2.67	+1.1%	-8.2%	+2.0%	-4.4%	+1.3%	+6.6%	—
May 9, 2025	AMC	-0.17	-0.22	-29.4%	2.60	+1.9%	-0.8%	-5.8%	-2.9%	+0.4%	-0.4%	—
Mar 12, 2025	AMC	-0.20	-0.19	+5.0%	2.81	+1.4%	+2.1%	-2.4%	+0.0%	+0.0%	+0.0%	—
Nov 12, 2024	AMC	-0.20	-0.16	+20.0%	2.38	-10.9%	+5.5%	+1.6%	-0.8%	+2.4%	-0.8%	—
Aug 6, 2024	AMC	-0.19	-0.22	-15.8%	2.98	-1.7%	-4.0%	-0.3%	+0.4%	-0.7%	+3.9%	—
May 14, 2024	AMC	-0.15	-0.21	-40.0%	2.38	-0.8%	-3.4%	+0.0%	+0.0%	-0.9%	+2.2%	—
Mar 6, 2024	AMC	-0.20	-0.16	+20.0%	2.53	-2.8%	+4.3%	-0.4%	-3.0%	-3.5%	+1.6%	—
Nov 6, 2023	AMC	-0.17	-0.15	+11.8%	3.34	-3.0%	-3.0%	+0.0%	-4.6%	+1.6%	-2.5%	—
Aug 8, 2023	AMC	-0.17	-0.24	-41.2%	3.10	+4.5%	+0.0%	+3.5%	+0.0%	-2.2%	+0.6%	—
May 15, 2023	AMC	-0.68	-0.53	+22.1%	1.84	-8.7%	-8.7%	+4.8%	-3.4%	+5.9%	+5.6%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 12	Piper Sandler	Maintains	Overweight → Overweight	—	$2.60	$2.65	+1.9%	-0.8%	-5.8%	-2.9%	+0.4%	-0.4%
Nov 2	Piper Sandler	Maintains	Overweight → Overweight	—	$3.77	$3.29	-12.7%	-11.4%	+3.1%	-3.0%	-3.0%	+0.0%
Jun 12	Piper Sandler	Maintains	Overweight → Overweight	—	$1.69	$1.90	+12.4%	+7.7%	+1.6%	+7.6%	+3.0%	+16.1%
May 17	National Alliance Securities	Maintains	Buy → Buy	—	$1.68	$1.76	+4.8%	+4.8%	-3.4%	+5.9%	+5.6%	-6.8%
Mar 31	Alliance Global Partners	Maintains	Buy → Buy	—	$1.06	$1.07	+0.9%	+6.6%	-4.4%	+0.0%	+5.6%	-4.4%
Mar 11	H.C. Wainwright	Maintains	Buy → Buy	—	$9.90	$9.15	-7.6%	-3.0%	-14.1%	-3.6%	-5.7%	+0.0%
Mar 29	Rodman & Renshaw	Maintains	Buy → Buy	—	$248437.50	$257812.50	+3.8%	-3.8%	+2.0%	-1.9%	-2.0%	-4.0%
Jan 7	H.C. Wainwright	Maintains	Buy → Buy	—	$332812.50	$370312.50	+11.3%	+0.0%	+15.5%	-2.4%	-12.5%	+0.0%
Mar 13	Oppenheimer	Downgrade	Outperform → Perform	—	—	—	—	—	—	—	—	—
Nov 26	Oppenheimer	Maintains	Outperform → Outperform	—	—	—	—	—	—	—	—	—
May 8	Cowen & Co.	Maintains	Outperform → Outperform	—	—	—	—	—	—	—	—	—

Data updated apr 26, 2026 3:51pm · Source: massive.com